

* Vestische Youth Hospital, University of Witten-Herdecke, Datteln, Germany
Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany
| ABSTRACT |
|---|
|
|
|---|
Methods. We studied changes in insulin sensitivity indices (ISIs) for glucose metabolism (homeostasis model assessment and quantitative insulin sensitivity check index) and fat metabolism (free fatty acids) during a 1-year period among obese children who attended an obesity intervention program. The children were divided into 4 groups according to their changes in body mass index (BMI) SD score (SDS), as follows: group I, decrease in SDS-BMI of
0.5; group II, decrease in SDS-BMI of
0.25 to <0.5; group III, decrease in SDS-BMI of <0.25; group IV, increase in SDS-BMI.
Results. Fifty-seven obese children (age range: 614 years; median age: 10 years; 46% boys) were included in the study. The 4 groups did not differ with respect to age, gender, degree of overweight (SDS-BMI), or ISI values at baseline. An increase in SDS-BMI (group IV, n = 12) was followed by a significant decrease in ISI values. The ISIs improved for group I (n = 9), whereas there were no significant changes in these parameters for group II (n = 21) and group III (n = 15).
Conclusions. During a 1-year period, an increase in weight among obese children was associated with a decrease in insulin sensitivity. Weight loss was followed by significant improvement in insulin sensitivity for glucose and fat metabolism but only if the SDS-BMI decreased by
0.5 during the 1-year period.
Key Words: insulin sensitivity obesity children reduction of overweight
Abbreviations: BMI, body mass index SDS, SD score ISI, insulin sensitivity index FFA, free fatty acid HOMA, homeostasis model assessment QUICKI, quantitative insulin sensitivity check index
Obesity is related to an impairment in insulin sensitivity not only in adulthood1,2 but even in childhood.3 Cardiovascular comorbidity of obesity is associated with risk factors such as dyslipidemia, hypertension, and impaired glucose metabolism (metabolic syndrome), which are attributed to disturbances in insulin sensitivity.1,2
Weight loss is the appropriate approach to increasing insulin sensitivity and thus treating cardiovascular risk factors in obesity.4 Studies addressing the amount of weight reduction required to improve insulin sensitivity have not yet been performed among obese children and adolescents. Therefore, we studied insulin sensitivity index (ISI) values of glucose and fat metabolism among obese children and adolescents during a 1-year period, in relation to the degree of weight loss of the patients.
| METHODS |
|---|
|
|
|---|
The 1-year outpatient Obeldicks program is based on physical exercise, nutrition education (high-carbohydrate, fat-reduced diet), and behavioral therapy. including individual psychologic care of the child and his or her family.6,7 An interdisciplinary team of pediatricians, dietitians, psychologists, and exercise physiologists are responsible for the training.
Fasting serum insulin, free fatty acid (FFA), and blood glucose concentrations were measured at baseline and 1 year later. The children and their parents were precisely instructed that the children were to fast for a period of
14 hours. The children were not observed overnight in a clinical study unit. Insulin concentrations were measured with a microparticle enzyme assay (Abboth, Bau Nauheim, Germany). Blood glucose and FFA concentrations were determined with a colorimetric test (Vitros GLU-Analyseplättchen, Neckar-Gmünd, Germany; Wako Freie Fettsäure, Neuss, Germany). Intraassay and interassay coefficients of variation were <10% for all methods.
Homeostasis model assessment (HOMA)8 and the quantitative insulin sensitivity check index (QUICKI)9,10 were used to detect the degree of insulin sensitivity in glucose metabolism. The sensitivity was calculated from the fasting glucose and insulin concentrations with the following formulas: ISI-HOMA = 22.5/(insulin [mU/L] x glucose [mmol/L]); ISI-QUICKI = 1/[log(insulin [mU/L]) + log(glucose [mg/dL])].
ISI-FFA was calculated with the following formula: 2/(insulin [mU/L] x FFA [mmol/L]) + 1.11 The lower limit of the interquartile range for ISI-HOMA among healthy children of normal weight depends on age and gender (prepubertal boys: 0.87; pubertal boys: 0.49; prepubertal girls: 0.78; pubertal girls: 0.44).12
Height and weight were measured at baseline and 1 year later. The weight status was recorded as BMI and BMI SD score (SDS). Because BMI is not normally distributed, we used the LMS method to calculate SDS-BMI, which summarizes the data in terms of 3 smooth age-specific curves called lambda (L), mu (M), and sigma (S).5,13 The M and S curves correspond to the median and coefficient of variation of BMI, respectively, for German children of each age and gender, whereas the L curve allows for the substantial age-dependent skew in the BMI distribution. The assumption underlying the least mean squares method is that, after Box-Cox power transformation, the data for each age are normally distributed.13
The pubertal developmental stage was determined according to the method of Marshall and Tanner,14,15 and subjects were categorized into 2 groups (prepubertal: boys in pubic hair and gonadal stage I and girls in pubic hair and breast stage I; pubertal: boys in pubic hair and gonadal stage
II and girls in pubic hair and breast stage
II). The children were divided into 4 groups according to their changes in SDS-BMI at 1 year, as follows: group I, decrease in SDS-BMI of
0.5; group II, decrease in SDS-BMI of
0.25 to <0.5; group III, decrease in SDS-BMI of <0.25; group IV, increase in SDS-BMI. This division was used because, in a previous study, we demonstrated improvement of cardiovascular risk factors such as hypertension and dyslipidemia only if the SDS-BMI decreased by
0.5 during a 1-year period.16 We also studied ISI values during a 3-month period among 10 healthy, normal-weight children (age range: 5-14 years; median age: 11 years; median SDS-BMI: 0.54), without significant weight changes.
Statistical analyses were performed with Winstat software (Fitch Software, Staufen, Germany). P < .05 was considered statistically significant. Values are expressed as median and interquartile range. Statistically significant differences were tested with the nonparametric Kruskal-Wallis test for quantitative items and with the nonparametric Wilcoxon test for paired observations. Changes in insulin indices of glucose metabolism (ISI-HOMA and ISI-QUICKI) during the 1-year period were correlated with changes in insulin sensitivity of fat metabolism (ISI-FFA) and with changes in degree of overweight (SDS-BMI) with Spearman rank correlations. ISI values for the obese and normal-weight children at baseline were compared with the nonparametric Kruskal-Wallis test. Two coefficients of variation were calculated for ISI-HOMA, ISI-QUICKI, and ISI-FFA on the basis of the data for the 10 normal-weight children, representing between-subject variation at baseline and within-subject variation between the 2 measurements during the 3-month period. The study was approved by the local ethics committee of the University of Witten-Herdecke.
| RESULTS |
|---|
|
|
|---|
|
None of the 57 obese children discontinued the Obeldicks intervention program. Forty-five participants (79%) in the outpatient training program reduced their weight (SDS-BMI). Age, gender, pubertal stage, and SDS-BMI of the children according to their weight changes are presented in Table 2. The 4 groups did not differ significantly in terms of age (P = .069), gender (P = .790), degree of overweight (SDS-BMI) (P = .435), or ISI values at baseline (ISI-HOMA: P = .091; ISI-QUICKI: P = .092; ISI-FFA: P = .511).
|
0.5 (group I) was associated with significant increases in ISI values (ISI-HOMA, ISI-QUICKI, and ISI-FFA) (Table 3). All 9 children with SDS-BMI decreases of
0.5 improved their ISI values for glucose metabolism (ISI-HOMA and ISI-QUICKI) (Figs 1 and 2). Eight of 9 children with SDS-BMI decreases of
0.5 improved their ISI values for fat metabolism (ISI-FFA) (Fig 3).
|
|
|
|
When the 3 children with onset of puberty during the 1-year study period were omitted from group II, there were still no significant changes in ISI-HOMA (P = .420), ISI-QUICKI (P = .528), and ISI-FFA (P = .306). When the 4 children with onset of puberty during the 1-year study period were omitted from group III, there were no significant changes in ISI-HOMA (P = .505), ISI-QUICKI (P = .618), and ISI-FFA (P = .286).
Increases in SDS-BMI (group IV) were associated with significant decreases in ISI values (ISI-HOMA, ISI-QUICKI, and ISI-FFA) for 10 of the 12 children (Table 3). The improvement in ISI values for the other 2 children with increasing overweight was minimal (improvement in ISI-HOMA: <0.05; improvement in ISI-QUICKI: <0.01; improvement in ISI-FFA: <0.1) (Figs 13). The changes in ISI-FFA were significantly correlated with changes in ISI-HOMA (r = 0.76; P < .001) and ISI-QUICKI (r = 0.76; P < .001).
| DISCUSSION |
|---|
|
|
|---|
0.5) during the 1-year period, whereas reduction of SDS-BMI of <0.5 showed no significant improvement. Because of its moderate sample size, our study is not sufficient to define a clear cutoff point for SDS-BMI change that leads to decreases in ISI values. In larger cohorts, insulin sensitivity may significantly improve at a lower level of weight reduction.
A reduction in SDS-BMI of 0.5 can be achieved with nearly stable weight loss during a 1-year period among growing obese children in multidisciplinary outpatient intervention programs.18 In an ongoing study, we demonstrated a mean decrease in SDS-BMI during a 1-year period of
0.5 among 132 obese participants in the Obeldicks intervention program.19 In an intention-to-treat analysis, 55% of all participants decreased their overweight by at least 0.5 SDS-BMI.19
Corresponding to our results, SDS-BMI reductions of
0.5 among obese children led to improvement of cardiovascular risk factors (reductions in hypertension, triglyceride concentrations, and LDL cholesterol concentrations and an increase in HDL cholesterol concentrations).16 Impairment of insulin sensitivity is the main cause of hypertriglyceridemia, decreases in HDL cholesterol concentrations, and increased blood pressure in obesity and is correlated with the degree of overweight.2,20
The changes in ISI values were attributable to significant changes in serum insulin and FFA levels, whereas fasting blood glucose levels remained stable during the 1-year period. This is in accordance with other studies that demonstrated decreasing FFA and insulin levels during weight loss among children and adults.21,22
The observed changes in the insulin sensitivity in our sample represented the effects of weight loss based on reduced fat intake and/or increased physical activity attributable to an outpatient training program.6,7 There has been controversy regarding the relative effects of energy restriction versus weight loss, with some studies suggesting a dominant role for reduced energy intake23,24 and others for weight loss per se.25,26 Both energy restriction and weight loss have beneficial effects on insulin action.27 Furthermore, physical activity by itself improves insulin sensitivity.28
In our sample, there were significant decreases in ISI values among children with increases in weight (group IV). In addition to the effect of increasing overweight, this could probably be explained in part on the basis of puberty progression during a 1-year period.29 However, no child in this group entered puberty during the study period.
Changes in ISIs for glucose metabolism (ISI-HOMA and ISI-QUICKI) were correlated significantly with changes in ISIs for fat metabolism (ISI-FFA). Furthermore, significant improvement in ISIs for glucose and fat metabolism were observed only among children with SDS-BMI decreases of
0.5. Therefore, insulin sensitivity for glucose metabolism seems to be related to insulin sensitivity for fat metabolism.
| CONCLUSIONS |
|---|
|
|
|---|
0.5. This finding suggests that comprehensive treatment strategies for childhood obesity are able to reduce risk factors for cardiovascular disease such as insulin resistance.
| FOOTNOTES |
|---|
Reprint requests to (T.R.) Vestische Youth Hospital, University of Witten-Herdecke, Dr F. Steiner Strasse 5, 45711 Datteln, Germany. E-mail: t.reinehr{at}kinderklinik-datteln.de
No conflict of interest declared.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. P Hunt, A. Ford, M. A Sabin, E. C Crowne, and J. P H Shield Clinical measures of adiposity and percentage fat loss: which measure most accurately reflects fat loss and what should we aim for? Arch. Dis. Child., May 1, 2007; 92(5): 399 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosenbaum, C. Nonas, R. Weil, M. Horlick, I. Fennoy, I. Vargas, P. Kringas, and and The El Camino Diabetes Prevention Group School-Based Intervention Acutely Improves Insulin Sensitivity and Decreases Inflammatory Markers and Body Fatness in Junior High School Students J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 504 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wunsch, G. de Sousa, A. M. Toschke, and T. Reinehr Intima-Media Thickness in Obese Children Before and After Weight Loss Pediatrics, December 1, 2006; 118(6): 2334 - 2340. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reinehr, G. de Sousa, A. M. Toschke, and W. Andler Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 490 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kaitosaari, T. Ronnemaa, J. Viikari, O. Raitakari, M. Arffman, J. Marniemi, K. Kallio, K. Pahkala, E. Jokinen, and O. Simell Low-Saturated Fat Dietary Counseling Starting in Infancy Improves Insulin Sensitivity in 9-Year-Old Healthy Children: The Special Turku Coronary Risk Factor Intervention Project for Children (STRIP) study Diabetes Care, April 1, 2006; 29(4): 781 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Sabin, A L Ford, J M P Holly, L P Hunt, E C Crowne, and J P H Shield Characterisation of morbidity in a UK, hospital based, obesity clinic Arch. Dis. Child., February 1, 2006; 91(2): 126 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reinehr, G. de Sousa, C. L. Roth, and W. Andler Androgens before and after Weight Loss in Obese Children J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5588 - 5595. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bobbert, H. Rochlitz, U. Wegewitz, S. Akpulat, K. Mai, M. O. Weickert, M. Mohlig, A. F.H. Pfeiffer, and J. Spranger Changes of Adiponectin Oligomer Composition by Moderate Weight Reduction Diabetes, September 1, 2005; 54(9): 2712 - 2719. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Joffe Pharmacotherapy for Adolescent Obesity: A Weighty Issue JAMA, June 15, 2005; 293(23): 2932 - 2934. [Full Text] [PDF] |
||||
![]() |
N. Santoro, M. Di Nardo, A. Amato, L. Perrone, and E. M. del Giudice Improvement of Glucose Homeostasis After Weight Loss in Obese Children Pediatrics, May 1, 2005; 115(5): 1441 - 1441. [Full Text] [PDF] |
||||
![]() |
T. Reinehr, W. Andler, W. Kiess, and T. Kapellen Improvement of Glucose Homeostasis After Weight Loss in Obese Children: In Reply Pediatrics, May 1, 2005; 115(5): 1441 - 1442. [Full Text] [PDF] |
||||
![]() |
For Obese Children and Adolescents, Small Steps Help Journal Watch Pediatrics and Adolescent Medicine, February 1, 2005; 2005(201): 1 - 1. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||